Search Results - "Ignaszewski, M."

Refine Results
  1. 1
  2. 2

    To VAD or Not to VAD: A Case of Durable Left Ventricular Assist Device Implantation in a COVID-19 Patient by Ignaszewski, M., Pandrangi, K., Kabbany, M., Wilcox, J.E., Vorovich, E.E., Tibrewala, A., Raza, Y., Ahmad, F., Ghafourian, K., Rich, J.D., Pawale, A.A., Pham, D.T., Yancy, C.W., Okwuosa, I.S.

    “…The management of patients with heart failure who contract COVID-19 and those who develop heart failure as a consequence of the disease is challenging. The use…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Argo: THE CHALLENGE OF CONTINUING 10 YEARS OF PROGRESS by ROEMMICH, DEAN

    Published in Oceanography (Washington, D.C.) (01-09-2009)
    “…In only 10 years, the Argo Program has grown from an idea into a functioning global observing system for the subsurface ocean. More than 3000 Argo floats now…”
    Get full text
    Journal Article
  6. 6

    The Argo Program: Observing the Global Ocean with Profiling Floats by Roemmich, D, Johnson, G C, Riser, S, Davis, R, Gilson, J, Owens, W B, Garzoli, S L, Schmid, C, Ignaszewski, M

    Published in Oceanography (Washington, D.C.) (01-06-2009)
    “…The Argo Program has created the first global array for observing the subsurface ocean. Argo arose from a compelling scientific need for climate-relevant ocean…”
    Get full text
    Journal Article
  7. 7

    Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study by Haddad, Haissam, Bergeron, Sebastien, Ignaszewski, Andrew, Searles, Gregory, Rochdi, Driss, Dhage, Priyanka, Bastien, Natacha

    Published in CJC open (Online) (01-09-2020)
    “…To determine the effectiveness of sacubitril/valsartan 97/103 mg twice daily (b.i.d.) on tolerability, safety, and quality of life (QoL) in Canadian patients…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Treatment-naïve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: An unusual suspect by Ignaszewski, Maya, MD, Kohlitz, Patrick, MD

    Published in The American journal of emergency medicine (01-09-2017)
    “…Abstract Tumor lysis syndrome (TLS) is a potentially fatal condition defined both by laboratory and clinical criteria. It is caused by the catabolism of tumor…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support by Lamarche, Yoan, MD, Cheung, Anson, MD, Ignaszewski, Andrew, MD, Higgins, Jennifer, MD, Kaan, Annemarie, MCN RN, Griesdale, Donald E.G., MD, MPH, Moss, Robert, MD

    “…Objective Cardiogenic shock is associated with poor clinical outcomes. Extracorporeal life support is used in most centers for short-term circulatory support…”
    Get full text
    Journal Article
  12. 12

    The Health Benefits of a 12-Week Home-Based Interval Training Cardiac Rehabilitation Program in Patients With Heart Failure by Safiyari-Hafizi, Hedieh, MSc, Taunton, Jack, MD, Ignaszewski, Andrew, MD, Warburton, Darren E.R., PhD

    Published in Canadian journal of cardiology (01-04-2016)
    “…Abstract Background Recently, high-intensity interval training has been advocated for the rehabilitation of persons living with heart failure (HF). Home-based…”
    Get full text
    Journal Article
  13. 13

    Review of Eligibility for Cardiac Resynchronization Therapy by Hawkins, Nathaniel M., MD, Bennett, Matthew T., MD, Andrade, Jason G., MD, Virani, Sean A., MD, Krahn, Andrew D., MD, Ignaszewski, Andrew, MD, Toma, Mustafa, MD

    Published in The American journal of cardiology (15-07-2015)
    “…Cardiac resynchronization therapy (CRT) is underused. Recent guidelines have expanded indications for CRT to include less severe symptoms but now favor left…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Successful Weaning and Explantation of the Heartmate II Left Ventricular Assist Device by Lamarche, Yoan, MD, Kearns, Mark, MD, Josan, Kiranbir, MD, Bashir, Jamil, MD, Ignaszewski, Andrew, MD, Kaan, Annemarie, RN, MCN, Kealy, Jennifer, RN, MSN, Moss, Robert, MD, Cheung, Anson, MD

    Published in Canadian journal of cardiology (01-05-2011)
    “…Abstract Background Ventricular assist devices (VADs) are used in cases of heart failure refractory to medical therapy. Most VADs are used as a bridge to heart…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Thrombosis and failure of a HeartMate II Device in the absence of alarms by Bashir, Jamil, MD, Cheung, Anson, MD, Kaan, AnneMarie, RN, Kearns, Mark, MD, Ibey, Andrew, PEng, Ignaszewski, Andrew, MD

    “…Next-generation left ventricular assist devices such as the HeartMate II (Thoratec Corporation, Pleasanton, CA) have significantly improved patient outcomes…”
    Get full text
    Journal Article
  19. 19
  20. 20

    4.10 UPDATE ON RANDOMIZED, PLACEBO-CONTROLLED TRIALS IN THE LAST DECADE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN CHILD AND ADOLESCENT PATIENTS: A SYSTEMATIC REVIEW by Ignaszewski, Martha J., MD, Waslick, Bruce D., MD

    “…Objectives: Depression is a common condition among children and adolescents, although the evidence base for treatment for patients in this age range has been…”
    Get full text
    Journal Article